Mechanism of cardioprotection by early ischemic preconditioning.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMC 2932886)

Published in Cardiovasc Drugs Ther on June 01, 2010

Authors

Xiulan Yang1, Michael V Cohen, James M Downey

Author Affiliations

1: Department of Physiology, College of Medicine, University of South Alabama, MSB 3074, Mobile, AL 36688, USA.

Articles citing this

Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov (2012) 2.33

New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66

Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ Res (2012) 1.31

Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol (2011) 1.21

Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. Br J Pharmacol (2014) 1.10

Protein Oxidative Modifications: Beneficial Roles in Disease and Health. J Biochem Pharmacol Res (2013) 1.07

Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury. Exp Diabetes Res (2011) 1.03

SIRT1-mediated acute cardioprotection. Am J Physiol Heart Circ Physiol (2011) 1.02

The mitochondrial K(ATP) channel--fact or fiction? J Mol Cell Cardiol (2012) 0.99

Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning. Proc Natl Acad Sci U S A (2012) 0.99

Sirtuin regulation in aging and injury. Biochim Biophys Acta (2015) 0.98

Extent of mitochondrial hexokinase II dissociation during ischemia correlates with mitochondrial cytochrome c release, reactive oxygen species production, and infarct size on reperfusion. J Am Heart Assoc (2012) 0.97

Role of microRNAs in cardiac preconditioning. J Cardiovasc Pharmacol (2010) 0.94

Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol Med (2013) 0.94

Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptor. J Mol Cell Cardiol (2010) 0.88

Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models. J Cardiothorac Surg (2013) 0.87

Protein redox modification as a cellular defense mechanism against tissue ischemic injury. Oxid Med Cell Longev (2014) 0.86

Environmental and genetic preconditioning for long-term anoxia responses requires AMPK in Caenorhabditis elegans. PLoS One (2011) 0.85

Differential STAT3 signaling in the heart: Impact of concurrent signals and oxidative stress. JAKSTAT (2012) 0.85

The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism. Br J Pharmacol (2015) 0.85

The "Goldilocks Zone" from a redox perspective-Adaptive vs. deleterious responses to oxidative stress in striated muscle. Front Physiol (2014) 0.84

The role of hexokinase in cardioprotection - mechanism and potential for translation. Br J Pharmacol (2014) 0.84

Conditional knockout of myocyte focal adhesion kinase abrogates ischemic preconditioning in adult murine hearts. J Am Heart Assoc (2013) 0.83

N-n-butyl haloperidol iodide ameliorates cardiomyocytes hypoxia/reoxygenation injury by extracellular calcium-dependent and -independent mechanisms. Oxid Med Cell Longev (2013) 0.83

Mitochondrial function in hypoxic ischemic injury and influence of aging. Prog Neurobiol (2016) 0.83

LIF and the heart: just another brick in the wall? Eur Cytokine Netw (2013) 0.82

KATP Channels in the Cardiovascular System. Physiol Rev (2016) 0.82

A2B adenosine receptors inhibit superoxide production from mitochondrial complex I in rabbit cardiomyocytes via a mechanism sensitive to Pertussis toxin. Br J Pharmacol (2011) 0.82

Myocardial ischemic reperfusion induces de novo Nrf2 protein translation. Biochim Biophys Acta (2014) 0.81

Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of Fallot repair: a randomized controlled trial. J Am Heart Assoc (2013) 0.81

ERK1/2-Egr-1 Signaling Pathway-Mediated Protective Effects of Electroacupuncture in a Mouse Model of Myocardial Ischemia-Reperfusion. Evid Based Complement Alternat Med (2014) 0.80

Cardiac protection by preconditioning is generated via an iron-signal created by proteasomal degradation of iron proteins. PLoS One (2012) 0.80

Angiotensin II and ischemic preconditioning synergize to improve mitochondrial function while showing additive effects on ventricular postischemic recovery. J Cardiovasc Pharmacol (2014) 0.78

Adenosine 2B Receptor Activation Reduces Myocardial Reperfusion Injury by Promoting Anti-Inflammatory Macrophages Differentiation via PI3K/Akt Pathway. Oxid Med Cell Longev (2015) 0.78

Ethanol promotes new vessel growth in remote nonischemic myocardium. J Surg Res (2014) 0.78

Acute hyperglycemia abolishes ischemic preconditioning by inhibiting Akt phosphorylation: normalizing blood glucose before ischemia restores ischemic preconditioning. Oxid Med Cell Longev (2013) 0.78

Novel therapeutic strategies for ischemic heart disease. Pharmacol Res (2014) 0.77

Myocardial ischemic protection in natural mammalian hibernation. Basic Res Cardiol (2015) 0.77

Preconditioning of the response to ischemia/ reperfusion-induced plasma leakage in hamster cheek pouch microcirculation. Clinics (Sao Paulo) (2012) 0.77

The pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondria. Tex Heart Inst J (2013) 0.77

Pre-conditioning with low-level laser (light) therapy: light before the storm. Dose Response (2014) 0.77

Plasticity of sarcolemmal KATP channel surface expression: relevance during ischemia and ischemic preconditioning. Am J Physiol Heart Circ Physiol (2016) 0.76

Extracellular Adenosine Formation by Ecto-5'-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning. PLoS One (2015) 0.75

Filling GAPs in the understanding of cardioprotection induced by GPCR activation: RGS proteins modulate ischaemic injury. Cardiovasc Res (2011) 0.75

Cardioprotection by PI3K-mediated signaling is required for anti-arrhythmia and myocardial repair in response to ischemic preconditioning in infarcted pig hearts. Lab Invest (2015) 0.75

Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium. Int J Mol Med (2017) 0.75

The differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion. Cardiovasc J Afr (2016) 0.75

Visual Evidence of Ischemic Preconditioning During PCI Using 80 Lead ECG Body Surface Mapping. Clin Med Insights Case Rep (2011) 0.75

DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning. Oncotarget (2017) 0.75

Articles cited by this

(truncated to the top 100)

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82

Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med (2008) 9.40

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol (2003) 6.27

Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest (2004) 4.97

Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation (1991) 4.30

Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation (2007) 3.65

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res (2004) 3.63

Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J (1988) 3.41

Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A (2001) 3.28

Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation (2008) 3.13

Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J (1995) 2.92

Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res (2002) 2.84

Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol (1993) 2.67

New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res (2004) 2.63

Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation (1993) 2.56

Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective. Circ Res (2002) 2.50

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet (2007) 2.48

Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res (2001) 2.46

Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res (1990) 2.45

Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci U S A (1999) 2.44

Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem (1998) 2.44

Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res (2004) 2.40

Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res (2006) 2.39

Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol (2004) 2.18

Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem (1976) 2.15

Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol (1997) 2.15

Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol (1994) 2.04

A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem (1997) 2.03

Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res (2005) 1.86

Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res (1989) 1.86

Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation (2003) 1.80

Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res (1995) 1.75

Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res (2008) 1.74

Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res (2005) 1.74

The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol (2009) 1.66

Inhibition of anoxia-induced injury in heart myocytes by cyclosporin A. J Mol Cell Cardiol (1991) 1.64

Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol (2003) 1.63

Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation (2003) 1.60

Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res (2008) 1.60

Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation (2004) 1.60

Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol Heart Circ Physiol (2005) 1.59

Kinetic evidence for a heart mitochondrial pore activated by Ca2+, inorganic phosphate and oxidative stress. A potential mechanism for mitochondrial dysfunction during cellular Ca2+ overload. Eur J Biochem (1988) 1.59

Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg (1999) 1.59

Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol (2007) 1.58

Mitochondrial K(ATP) channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc Res (2001) 1.57

Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation (2004) 1.52

Cardioprotective signaling to mitochondria. J Mol Cell Cardiol (2008) 1.49

The molecular composition of the mitochondrial permeability transition pore. J Mol Cell Cardiol (2009) 1.48

Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res (2008) 1.44

Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res (2001) 1.43

Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol (2002) 1.43

Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol (2008) 1.42

Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res (2004) 1.42

The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol (2009) 1.40

The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition. J Biol Chem (2006) 1.38

Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc Res (2006) 1.35

Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. Circ Res (1993) 1.35

Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection. J Clin Invest (2002) 1.34

Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res (2005) 1.34

Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice. Am J Physiol Heart Circ Physiol (2004) 1.34

Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol (1999) 1.33

Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res (1997) 1.33

NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol (2004) 1.29

Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen. J Biol Chem (2002) 1.26

Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther (1994) 1.25

GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol (2007) 1.24

Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol (2009) 1.21

Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem (2004) 1.20

Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. J Pharmacol Exp Ther (2008) 1.19

Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol (2006) 1.19

Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol (1995) 1.18

Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake. Cardiovasc Res (2009) 1.14

Ischemic preconditioning translocates PKC-delta and -epsilon, which mediate functional protection in isolated rat heart. Am J Physiol (1998) 1.14

Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation (1998) 1.12

The expression of constitutively active isotypes of protein kinase C to investigate preconditioning. J Biol Chem (1998) 1.11

Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res (2002) 1.09

Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol (1995) 1.08

NECA at reperfusion limits infarction and inhibits formation of the mitochondrial permeability transition pore by activating p70S6 kinase. Basic Res Cardiol (2006) 1.07

Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc Res (2009) 1.05

Targeting sphingosine-1-phosphate signalling for cardioprotection. Curr Opin Pharmacol (2008) 1.04

Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J (2005) 1.02

Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart. Basic Res Cardiol (1999) 1.02

Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol (1991) 1.01

Local delivery of PKCepsilon-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation. Am J Physiol Heart Circ Physiol (2007) 1.00

Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol Heart Circ Physiol (2002) 1.00

Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol (2006) 0.98

Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effects of in vivo deltaPKC inhibition. Circ Res (2002) 0.97

Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C. Am J Physiol Heart Circ Physiol (2008) 0.96

Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J Cardiovasc Pharmacol (2001) 0.94

Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection. J Mol Cell Cardiol (1996) 0.93

Attenuation of infarction in cynomolgus monkeys: preconditioning and postconditioning. Basic Res Cardiol (2009) 0.93

Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion. Cardiovasc Res (2002) 0.93

Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res Cardiol (2007) 0.93

Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res (2002) 0.91

Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease. Annu Rev Med (1996) 0.90

Preconditioning-mimetics bradykinin and DADLE activate PI3-kinase through divergent pathways. J Mol Cell Cardiol (2007) 0.90

Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol (1996) 0.90

Alpha 1-adrenoceptor activation increases ecto-5'-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation (1995) 0.89

Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc Res (1998) 0.89

Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion. J Mol Cell Cardiol (2000) 0.89

Articles by these authors

Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev (2003) 3.83

Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol (2004) 2.94

Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res (2006) 2.39

Signaling pathways in ischemic preconditioning. Heart Fail Rev (2007) 2.26

Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res (2005) 1.86

Total liquid ventilation provides ultra-fast cardioprotective cooling. J Am Coll Cardiol (2007) 1.73

Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol (2003) 1.63

The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation (2007) 1.61

Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol Heart Circ Physiol (2005) 1.59

Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol (2007) 1.58

Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts. Cardiovasc Drugs Ther (2013) 1.51

Dose-response relationships of the protective and antiprotective effects of acute ethanol exposure in isolated rabbit hearts. Heart Dis (2002) 1.42

Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol (2004) 1.41

Why do we still not have cardioprotective drugs? Circ J (2009) 1.40

Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol (2007) 1.38

Bypassing big pharma. Circulation (2007) 1.38

Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res (2005) 1.33

NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol (2004) 1.29

cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res (2007) 1.25

Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc Res (2002) 1.17

Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res Cardiol (2008) 1.14

Cardioprotective PKG-independent NO signaling at reperfusion. Am J Physiol Heart Circ Physiol (2010) 1.12

NECA at reperfusion limits infarction and inhibits formation of the mitochondrial permeability transition pore by activating p70S6 kinase. Basic Res Cardiol (2006) 1.07

Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism. Am J Physiol Heart Circ Physiol (2004) 1.06

Mapping preconditioning's signaling pathways: an engineering approach. Ann N Y Acad Sci (2008) 1.05

Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts. J Cardiovasc Pharmacol Ther (2012) 1.04

BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts. Eur Heart J (2009) 1.04

ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. Am J Physiol Heart Circ Physiol (2002) 1.03

Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts. Am J Physiol Heart Circ Physiol (2010) 1.00

Protection from post-conditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Res Cardiol (2006) 1.00

Ischemic postconditioning: from receptor to end-effector. Antioxid Redox Signal (2010) 0.98

Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol (2006) 0.98

The small chill: mild hypothermia for cardioprotection? Cardiovasc Res (2010) 0.97

Rapid cooling preserves the ischaemic myocardium against mitochondrial damage and left ventricular dysfunction. Cardiovasc Res (2009) 0.96

Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C. Am J Physiol Heart Circ Physiol (2008) 0.96

Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol (2002) 0.95

Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol Heart Circ Physiol (2004) 0.95

Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. J Mol Cell Cardiol (2004) 0.94

Attenuation of infarction in cynomolgus monkeys: preconditioning and postconditioning. Basic Res Cardiol (2009) 0.93

Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res Cardiol (2007) 0.93

The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc Res (2002) 0.93

Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. Am J Physiol Heart Circ Physiol (2005) 0.91

Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res (2002) 0.91

Preconditioning-mimetics bradykinin and DADLE activate PI3-kinase through divergent pathways. J Mol Cell Cardiol (2007) 0.90

Evidence for an intracellular localization of the adenosine A2B receptor in rat cardiomyocytes. Basic Res Cardiol (2011) 0.90

Making the heart resistant to infarction: how can we further decrease infarct size? Front Biosci (2008) 0.90

Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future. Br J Pharmacol (2014) 0.90

Acetylcholine-induced production of reactive oxygen species in adult rabbit ventricular myocytes is dependent on phosphatidylinositol 3- and Src-kinase activation and mitochondrial K(ATP) channel opening. J Mol Cell Cardiol (2003) 0.89

Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol (2002) 0.89

Localizing extracellular signal-regulated kinase (ERK) in pharmacological preconditioning's trigger pathway. Basic Res Cardiol (2005) 0.89

Peptide blockers of PKG inhibit ROS generation by acetylcholine and bradykinin in cardiomyocytes but fail to block protection in the whole heart. Am J Physiol Heart Circ Physiol (2004) 0.88

Is it time to translate ischemic preconditioning's mechanism of cardioprotection into clinical practice? J Cardiovasc Pharmacol Ther (2011) 0.88

Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning. Basic Res Cardiol (2008) 0.87

Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity. Basic Res Cardiol (2011) 0.87

Cardioprotection with adenosine A2 receptor activation at reperfusion. J Cardiovasc Pharmacol (2005) 0.87

Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. Am J Physiol Heart Circ Physiol (2002) 0.87

Myocardial protection with mild hypothermia. Cardiovasc Res (2011) 0.86